Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 189

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system

Open access
Yang, Jonathan A., Kato, Tomoko S., Shulman, Brittney P., Takayama, Hiroo, Farr, Maryjane, Jorde, Ulrich P., Mancini, Donna M., Naka, Yoshifumi, Schulze, P. Christian · 2012 · The Journal of Heart and Lung Transplantation

Abstract

Background Liver dysfunction increases post-surgical morbidity and mortality. The Model of End-stage Liver Disease (MELD) estimates liver function but can be inaccurate in patients receiving oral anticoagulation. We evaluated the impact of liver dysfunction on outcomes following ventricular assist device (VAD) implantation and the dynamic changes in liver dysfunction that occur during VAD support. Methods We retrospectively analyzed 255 patients (147 patients with pulsatile devices and 108 patients with continuous flow devices) who received a long-term VAD between 2000 and 2010. Liver dysfunction was estimated by MELD and MELD-eXcluding INR (MELD-XI), with patients grouped by score ≥17 or <17. Primary outcomes were on-VAD, post-transplant and overall survival. Results MELD and MELD-XI correlated highly (R ≥ 0.901, p<0.0001) in patients not on oral anticoagulation. Patients with MELD or MELD-XI <17 had improved on-VAD and overall survival (p<0.05) with a higher predictive power for MELD-XI. During VAD support, cholestasis initially worsened but eventually improved. Patients with pre-VAD liver dysfunction who survived to transplant had lower post-transplant survival (p=0.0193). However, if MELD-XI normalized during VAD support, post-transplant survival improved and was similar to that of patients with low MELD-XI scores. Conclusions MELD-XI is a viable alternative for assessing liver dysfunction in heart failure patients on oral anticoagulation. Liver dysfunction is associated with worse survival. However, if MELD-XI improves during VAD support, post-transplant survival is similar to those without prior liver dysfunction, suggesting an important prognostic role. We also found evidence of a transient cholestatic state following LVAD implantation that deserves further examination.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.healun.2012.02.027

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 189

Metadata

Authors
Yang, J. A., Kato, T. S., Shulman, B. P., Takayama, H., Farr, M., Jorde, U. P., Mancini, D. M., Naka, Y., & Schulze, P. C.
Venue
The Journal of Heart and Lung Transplantation
Publisher
Elsevier BV
Published
2012-06
Volume
31
Issue
6
Pages
601-610
ISSN
1053-2498 (ISSN-L)
OpenAlex
W2076317260
Cited by
189
References
1
FWCI
7.32
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. https://app.cochat.ai/papers/10.1016/j.healun.2012.02.027
The paper
Yang, J. A., Kato, T. S., Shulman, B. P., Takayama, H., Farr, M., Jorde, U. P., Mancini, D. M., Naka, Y., & Schulze, P. C. (2012). Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. The Journal of Heart and Lung Transplantation. https://doi.org/10.1016/j.healun.2012.02.027

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.